Clinical high risk for psychosis: the association between momentary stress, affective and psychotic symptoms

Acta Psychiatrica Scandinavica

Volumn 136, Issue 1, 2017, Pages 63-73

  van der Steen, Y ^a,b   Gimpel Drees, J ^c   Lataster, T ^a   Viechtbauer, W ^a   Simons, C J P ^a,d   Lardinois, M ^a   Michel, T M ^e   Janssen, B ^f   Bechdolf, A ^g   Wagner, M ^c   Myin Germeys, I ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF BONN   (Germany)

^d GGzE Foundation for Mental Health Care Eindhoven en de Kempen   (Netherlands)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY OF COLOGNE   (Germany)

Author keywords

clinical high risk; daily life stressors; experience sampling method; psychotic disorder

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; BRIEF PSYCHOTIC DISORDER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DELUSION; DELUSIONAL DISORDER; DYSTHYMIA; EMOTIONAL STRESS; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK PATIENT; HUMAN; LIFE EVENT; MAJOR DEPRESSION; MALE; MENTAL HEALTH; MOMENTARY STRESS; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSITIVE AND NEGATIVE SYNDROME SCALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL PHOBIA; SOCIAL STRESS; AFFECT; ECOLOGICAL MOMENTARY ASSESSMENT; MENTAL STRESS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; YOUNG ADULT;

ADULT; AFFECT; ECOLOGICAL MOMENTARY ASSESSMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; RISK; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 85014558913     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12714     Document Type: Article

References (61)

1. Corcoran CM, Walker E, Huot R et al. The stress cascade and schizophrenia: etiology and onset. Schizophr Bull 2003;29:671–692.
2. Myin-Germeys I, van Os J. Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev 2007;27:409–424.
3. Phillips LJ, Francey SM, Edwards J, McMurray N. Stress and psychosis: towards the development of new models of investigation. Clin Psychol Rev 2007;27:307–317.
4. van Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008;34:1095–1105.
5. Zubin J, Spring B. Vulnerability – a new view of schizophrenia. J Abnorm Psychol 1977;86:103–126.
6. Beards S, Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C. Life events and psychosis: a review and meta-analysis. Schizophr Bull 2013;39:740–747.
7. Varese F, Smeets F, Drukker M et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 2012;38:661–671.
8. Malla AK, Cortese L, Shaw TS, Ginsberg B. Life events and relapse in schizophrenia. A one year prospective study. Soc Psychiatry Psychiatr Epidemiol 1990;25:221–224.
9. Norman RM, Malla AK. A prospective study of daily stressors and symptomatology in schizophrenic patients. Soc Psychiatry Psychiatr Epidemiol 1994;29:244–249.
10. Yung AR, Yung AR, Pan Yuen H et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 2005;39:964–971.
11. Miller TJ, McGlashan TH, Rosen JL et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002;159:863–865.
12. Addington J, Stowkowy J, Cadenhead KS et al. Early traumatic experiences in those at clinical high risk for psychosis. Early Intervent Psychiatry 2013;7:300–305.
13. Bechdolf A, Thompson A, Nelson B et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand 2010;121:377–384.
14. Sahin S, Yuksel C, Guler J et al. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia. Early Intervent Psychiatry 2013;7: 414–420.
15. Tessner KD, Mittal V, Walker EF. Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders. Schizophr Bull 2011;37:432–441.
16. Thompson JL, Kelly M, Kimhy D et al. Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophr Res 2009;108:176–181.
17. Velthorst E, Nelson B, O'Connor K et al. History of trauma and the association with baseline symptoms in an Ultra-High Risk for psychosis cohort. Psychiatry Res 2013;210:75–81.
18. Tikka M, Luutonen S, Ilonen T et al. Childhood trauma and premorbid adjustment among individuals at clinical high risk for psychosis and normal control subjects. Early Intervent Psychiatry 2013;7:51–57.
19. Trotman HD, Holtzman CW, Walker EF et al. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr Res 2014;160:104–109.
20. Devylder JE, Ben-David S, Schobel SA, Kimhy D, Malaspina D, Corcoran CM. Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis. Psychol Med 2013;43:259–568.
21. Miller P, Lawrie SM, Hodges A, Clafferty R, Cosway R, Johnstone EC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2001;36:338–342.
22. Phillips LJ, Edwards J, McMurray N, Francey S. Comparison of experiences of stress and coping between young people at risk of psychosis and a non-clinical cohort. Behav Cogn Psychother 2012;40:69–88.
23. Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls. Schizophr Res 2011;129:29–35.
24. Lardinois M, Lataster T, Mengelers R, van Os J, Myin-Germeys I. Childhood trauma and increased stress sensitivity in psychosis. Acta Psychiatr Scand 2011;123:28–35.
25. Lataster T, Wichers M, Jacobs N et al. Does reactivity to stress cosegregate with subclinical psychosis? A general population twin study. Acta Psychiatr Scand 2009;119:45–53.
26. Myin-Germeys I, Delespaul P, van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med 2005;35:733–741.
27. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul P. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 2001b;58:1137–1144.
28. Collip D, Myin-Germeys I, van Os J. Does the concept of “sensitization” provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 2008;34:220–225.
29. Palmier-Claus JE, Dunn G, Lewis SW. Emotional and symptomatic reactivity to stress in individuals at ultra-high risk of developing psychosis. Psychol Med 2012;42:1003–1012.
30. Rapado-Castro M, McGorry PD, Yung A, Calvo A, Nelson B. Sources of clinical distress in young people at ultra high risk of psychosis. Schizophr Res 2015;165:15–21.
31. Lardinois M, Myin-Germeys I, Bak M, Mengelers R, van Os J, Delespaul PAEG. The dynamics of symptomatic and non-symptomatic coping with psychotic symptoms in the flow of daily life. Acta Psychiatr Scand 2007;116:71–75.
32. Myin-Germeys I, Nicolson NA, Delespaul PA. The context of delusional experiences in the daily life of patients with schizophrenia. Psychol Med 2001a;31:489–498.
33. Peters E, Lataster T, Greenwood K et al. Appraisals, psychotic symptoms and affect in daily life. Psychol Med 2012;42:1013–1023.
34. Miller T, McGlashan T, Woods S et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999;70:273–287.
35. Schultze-Lutter F, Addington J, Ruhrmann S, editors. Schizophrenia Proneness Instument, Adult version (SPI-A): Giovanni Fioriti Editore, 2007.
36. Bechdolf A, Muller H, Stutzer H et al. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophr Bull 2011;37(Suppl 2):S111–S121.
37. Wittchen HU, Fydrich T. Strukturiertes Klinisches Iterview für DSM-IV. Manual zum SKID-I und SKID-II. [Structured Clinical Interview for DSM.IV]. Göttingen: Hogrefe, 1997.
38. Korver N, Quee PJ, Boos HB, Simons CJ, de Haan L. Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res 2012;21:205–221.
39. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992;49:615–623.
40. Csikszentmihalyi M, Larson R. Validity and reliability of the experience-sampling method. J Nerv Ment Dis 1987;175:526–536.
41. Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os J. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med 2009;39:1533–1547.
42. Delespaul P. Assessing schizophrenia in daily life. Maastricht: Universitaire Pers; 1995.
43. Lataster T, Viechtbauer W, Oorschot M et al. Evidence for a two-factor positive and negative affect structure in daily life: presenting the Maastricht Momentary Mood Questionnaire (3MQ). internal communication.
44. APA. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
45. Junginger J, Barker S, Coe D. Mood theme and bizarreness of delusions in schizophrenia and mood psychosis. J Abnorm Psychol 1992;101:287–292.
46. Twisk JWR. Applied multilevel analysis. Cambridge, UK: Cambridge University Press; 2006.
47. Snijders TAB, Bosker RJ. Multilevel analysis: an introduction to basic and advanced multilevel modeling. London: Sage; 1999.
48. Myin-Germeys I, Krabbendam L, Delespaul PA, van Os J. Sex differences in emotional reactivity to daily life stress in psychosis. J Clin Psychiatry 2004;65:805–809.
49. STATACORP. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP, 2013.
50. Cullen AE, Fisher HL, Roberts RE, Pariante CM, Laurens KR. Daily stressors and negative life events in children at elevated risk of developing schizophrenia. Brit J Psychiatry 2014;204:354–360.
51. Cressman VL, Schobel SA, Steinfeld S et al. Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity. Npj Schizophrenia 2015;1:15020.
52. Rietdijk J, Ising HK, Dragt S et al. Depression and social anxiety in help-seeking patients with an ultra-high risk for developing psychosis. Psychiatry Res 2013;209:309–313.
53. Ventura J, Hellemann GS, Thames AD, Koellner V, Nuechterlein KH. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res 2009;113:189–199.
54. Gur RE, March M, Calkins ME et al. Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function. Schizophr Res 2015;166:322–327.
55. Piskulic D, Addington J, Cadenhead KS et al. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 2012;196:220–224.
56. Jalbrzikowski M, Sugar CA, Zinberg J, Bachman P, Cannon TD, Bearden CE. Coping styles of individuals at clinical high risk for developing psychosis. Early Intervent Psychiatry 2014;8:68–76.
57. Kommescher M, Wagner M, Putzfeld V et al. Coping as a predictor of treatment outcome in people at clinical high risk of psychosis. Early Intervent Psychiatry 2016;10:17–27.
58. Moritz S, Andreou C, Klingberg S, Thoering T, Peters MJV. Assessment of subjective cognitive and emotional effects of antipsychotic drugs. Effect by defect? Neuropharmacology 2013;72:179–186.
59. Yang LH, Link BG, Ben-David S et al. Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis. Schizophr Res 2015;168:9–15.
60. Hayes SC, Villatte M, Levin M, Hildebrandt M. Open, aware, and active: contextual approaches as an emerging trend in the behavioral and cognitive therapies. Annu Rev Clin Psychol 2011;7:141–168.
61. Strauss JS. The person with schizophrenia as a person. II: Approaches to the subjective and complex. Br J Psychiatry Suppl 1994;23:103–107.